BMJ Evidence-Based MedicineOpinion

Methylphenidate denied access to WHO’s list of essential medicines for the third time

Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
ebm.bmj

Using and distinguishing evidence from non-randomised studies of interventions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Wrong guidelines: why and how often they occur

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Correspondence to Doctor Antoine Vanier, Health Technology Assessment Department, Haute Autorité de Santé, La Plaine Saint-Denis, 93210, France; a.vanier{at}has-sante.fr In France, decisions for ...
ebm.bmj

Review: avulsion with phenol prevents recurrence of ingrown toenails

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

EBHC pyramid 5.0 for accessing preappraised evidence and guidance

Correspondence to: Dr Brian S Alper, DynaMed, EBSCO Health, 10 Estes Street, Ipswich, MA 01938, USA; balper{at}ebsco.com Practising evidence-based healthcare (EBHC) is integrating the best research ...